0001209191-22-052359.txt : 20221004 0001209191-22-052359.hdr.sgml : 20221004 20221004170551 ACCESSION NUMBER: 0001209191-22-052359 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221004 DATE AS OF CHANGE: 20221004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeronda Tyler CENTRAL INDEX KEY: 0001867033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 221292872 MAIL ADDRESS: STREET 1: C/O VYNE THERAPEUTICS STREET 2: 520 U.S. HIGHWAY 22, SUITE 204 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O UNITED AGENT GROUP, INC. STREET 2: 3411 SILVERSIDE RD TATNALL, BUILDING 104 CITY: WILMINGTON STATE: DE ZIP: 19810 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: C/O UNITED AGENT GROUP, INC. STREET 2: 3411 SILVERSIDE RD TATNALL, BUILDING 104 CITY: WILMINGTON STATE: DE ZIP: 19810 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-30 0 0001566044 VYNE Therapeutics Inc. VYNE 0001867033 Zeronda Tyler C/O VYNE THERAPEUTICS INC. NOT APPLICABLE DE 0 1 0 0 CFO Common Stock 2022-09-30 4 F 0 353 0.223 D 173359 D Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. /s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda 2022-10-04